Cholestasis: all 150 studies
Page 1 of 2. Open to participants first (18), then studies with results posted, then the rest; newest registration first within each.
- Nemolizumab for the Treatment of Moderate to Severe Chronic Hepatic PruritusNot yet recruitingNCT07843420Phase 2
- Vitamin D2 vs Vitamin D2 Plus Calcitriol in Cholestatic Children With Vitamin D DeficiencyRecruitingNCT07670611Phase 4
- Pediatric Evaluation and Registry for Liver Cholestasis in CanadaRecruitingNCT07411716
- Maralixibat for Intrahepatic Cholestasis of PregnancyNot yet recruitingNCT07389031Phase 2
- Long-Term Low-Intervention SafEty and Clinical Outcomes Clinical Study of LivmArli® in Patients With Alagille Syndrome or Progressive Familial Intrahepatic Cholestasis in the European Union (LEAP-EU)RecruitingNCT07290257Phase 4
- The Use of Near-Infrared Fluorescence Cholangiography With Indocyanine Green (ICG) in the Work Up of Neonatal CholestasisRecruitingNCT07250854Early Phase 1
- Congenital Heart Diseases and Developmental Assessment in Cholestatic Infants Under Two YearsNot yet recruitingNCT07247604
- A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSCRecruitingNCT06699121Phase 2
- PET/CT Scans Using the Tracer 11C-Csar, a Bile Acid Analog, to Depict and Visualize Cholestatic Disorders in Patients with Genetic Liver Disorders and Healthy IndividualsEnrolling by invitationNCT06610695
- Prediction Model for Early Biliary Stasis After Bariatric SurgeryNot yet recruitingNCT06385860
- Parenteral Nutrition Cycling for Prevention of Cholestatic Syndrome in NewbornRecruitingNCT06366880Not applicable
- Investigation of the Pruritogens of Liver-related DiseasesNot yet recruitingNCT06364969
- Tolerability of Enteral NAC in InfantsNot yet recruitingNCT06260566Phase 1
- Flare Type Self-expandable Metal Stents (SEMS) vs Plastic Stent for the Treatment of Difficult Common Bile Duct StoneNot yet recruitingNCT06170632Not applicable
- Impact of the Stool Color Scale on the Detection of Neonatal CholestasisNot yet recruitingNCT06048211
- FGF19 in Obstructive Cholestasis: "Unveil the Signal"RecruitingNCT05718349
- Association of Intrahepatic Cholestasis of Pregnancy and Chronic Placental InflammationRecruitingNCT05197387
- Biliary Atresia Study in Infants and ChildrenRecruitingNCT00345553
- Global Linerixibat Itch Study of Efficacy and Safety in Primary Biliary Cholangitis (PBC) (GLISTEN)CompletedNCT04950127Phase 3Results posted
- A Placebo-controlled Study of Volixibat in Subjects With Elevated Serum Bile Acids Associated With Intrahepatic Cholestasis of Pregnancy (OHANA)TerminatedNCT04718961Phase 2Results posted
- Open-Label Study of HTD1801 in Adult Subjects With Primary Biliary CholangitisCompletedNCT04604652Phase 2Results posted
- Evaluate the Safety, Tolerability, and PK of EP547 in Healthy Subjects and Subjects With Cholestatic or Uremic PruritusCompletedNCT04510090Phase 1Results posted
- An Extension Study of Maralixibat in Patients With Progressive Familial Intrahepatic Cholestasis (PFIC)CompletedNCT04185363Phase 3Results posted
- Linerixibat and Obeticholic Acid Drug Interaction Study in Healthy SubjectsCompletedNCT04053023Phase 1Results posted
- Pharmacokinetics (PKs) and Metabolism of Radiolabelled LinerixibatCompletedNCT03992014Phase 1Results posted
- A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)CompletedNCT03905330Phase 3Results posted
- Omegaven as Alternative Parenteral Fat NutritionCompletedNCT03662282Phase 3Results posted
- Long Term Safety & Efficacy Study Evaluating The Effect of A4250 in Children With PFICCompletedNCT03659916Phase 3Results posted
- This Study Will Investigate the Efficacy and Safety of A4250 in Children With PFIC Types 1 or 2CompletedNCT03566238Phase 3Results posted
- Comparison of Smoflipid to Soy-based Lipid Reduction for Cholestasis Prevention in Surgical NeonatesCompletedNCT03387579Phase 3Results posted
- Dose Response Study of GSK2330672 for the Treatment of Pruritus in Participants With Primary Biliary CholangitisCompletedNCT02966834Phase 2Results posted
- SMOFlipid to Lessen the Severity of Neonatal CholestasisTerminatedNCT02721277Phase 1/2Results posted
- Effectiveness of Multicomponent Lipid Emulsion in Preterm Infants Requiring Parenteral NutritionCompletedNCT02663453Phase 3Results posted
- Compassionate Use of Omegaven in ChildrenCompletedNCT02370251Phase 2/3Results posted
- Standard Lipid Therapy vs IVFE Minimization for Prevention of PNALDCompletedNCT02357576Phase 3Results posted
- Open Label Study to Evaluate Efficacy and Long Term Safety of LUM001 (Maralixibat) in the Treatment of Cholestatic Liver Disease in Patients With Progressive Familial Intrahepatic CholestasisCompletedNCT02057718Phase 2Results posted
- Biliary Excretion of Conjugated Bile Acids in Humans Measured by 11C-cholylsarcosine PET/CTCompletedNCT01879735Phase 1Results posted
- Omegaven® in the Treatment of Parenteral Nutrition (PN) Induced Liver InjuryCompletedNCT01845116Phase 2Results posted
- Compassionate Use of an Intravenous Fish Oil Emulsion in Infants With CholestasisCompletedNCT01601652Phase 1/2Results posted
- Prospective Randomized Clinical Trial of Intravenous Lipids and CholestasisCompletedNCT01555957Phase 3Results posted
- Low Dose Fat for the Prevention of Liver Disease in Babies With Gastrointestinal DisordersTerminatedNCT01373918Phase 4Results posted
- Compassionate Use of Omegaven to Reverse Parenteral Nutrition Induced CholestasisCompletedNCT01173159Not applicableResults posted
- Gentamicin in Preventing Post Endoscopic Retrograde Cholangiopancreatography (ERCP) Cholangitis in Non-calculus StentingCompletedNCT01148693Not applicableResults posted
- A Safety and Efficacy Study to Determine if Giving Intravenous Fish Oil Helps Children With Liver DiseaseTerminatedNCT00969332Phase 2Results posted
- Cholestasis Reversal: Efficacy of IV Fish OilCompletedNCT00910104Phase 2/3Results posted
- Evaluation of Omegaven™ Parenteral Nutrition in Patients With Total Parenteral Nutrition (TPN)-Induced CholestasisCompletedNCT00826020Phase 2Results posted
- Compassionate Use of Omegaven IV Fat EmulsionTerminatedNCT00816348Phase 2Results posted
- Compassionate Use of an Intravenous Fish Oil Emulsion in the Treatment of Liver Injury in InfantsCompletedNCT00738101Not applicableResults posted
- Compassionate Treatment of Patients With Inborn Errors of Bile Acid Metabolism With Cholic AcidCompletedNCT00007020Phase 3Results posted
- A Study to Assess the Genetic Variations in Bile Flow Disorders: Linking Progressive Familial Intrahepatic Cholestasis (PFIC)-Related Genes to Symptoms in Adults With Recurrent Cholestasis in SpainCompletedNCT07191704
- Needle-Knife Fistulotomy Vs. Standard Cannulation TrialCompletedNCT06694038Phase 1/2
- PET/CT Scans Using the Tracer 11C-Csar, a Bile Acid Analog, to Depict and Visualize Changes in the Hepatobiliary System in Patients With Primary Biliary Cholangitis Before and After Treatment.Active, not recruitingNCT06604923
- Mallampati Score for Prediction and Prognosis of Postoperative Mortality and Morbidity and Safety Profiles of Patients Undergoing Laparoscopic Cholecystectomy in Qassim RegionCompletedNCT06005701
- Outcome of Kasai Portoenterostomy in Biliary Atresia in Upper EgyptCompletedNCT05925543
- A Study of Endobiliary Radiofrequency Ablation in Malignant Biliary ObstructionsCompletedNCT05826639
- Osmotic Fragility in Red Blood Cells of Pediatric Patients With Cholestatic Liver DiseaseActive, not recruitingNCT05582447
- Risk Factor for Cholestasis in Neonates Receiving TPN(Total Parenteral Nutrition)Status unknownNCT05163145
- Ursodeoxycholic Acid Prevents Total Parenteral Nutrition CholestasisStatus unknownNCT05043194Not applicable
- Prevalence of Liver Disease in Patients Dependent on Parenteral NutritionCompletedNCT05011370
- Primary Versus Secondary Metal Stent Implantation in PTBDCompletedNCT04992585Not applicable
- Flushing of Internalized Percutaneous Transhepatic Biliary Drainage CathetersStatus unknownNCT04915703Not applicable
- Sems Placement With and Without Biliary Sphincterectomy in Patients With Malignant Biliary ObstructionStatus unknownNCT04805450Not applicable
- A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC)Active, not recruitingNCT04663308Phase 2
- SpyGlass™ Discover PercutaneousCompletedNCT04580940
- A Maralixibat Expanded Access Program for Patients With Cholestatic Pruritus Associated With Alagille Syndrome (ALGS)Approved for marketingNCT04530994
- Odevixibat for the Treatment of Progressive Familial Intrahepatic CholestasisNo longer availableNCT04483531
- Efficacy of 24 Month of Bezafibrate in Primary Sclerosing Cholangitis With Persistent Cholestasis Despite Ursodeoxycholic Acid TherapyStatus unknownNCT04309773Phase 3
- Linerixibat Long-term Safety, and Tolerability StudyActive, not recruitingNCT04167358Phase 3
- Treatment Outcomes in Bile Duct StonesCompletedNCT04145843
- Volumetric Laser Endomicroscopy's (VLE) Diagnostic Accuracy Validation Study: Impact on Clinical Management StudyStatus unknownNCT03951324
- Dry Blood Spot Screening Test for Neonatal Cholestasis PatientsStatus unknownNCT03667534
- "Endoscopy First" or "Laparoscopic Cholecystectomy First" for Patients With Intermediate Risk of CholedocholithiasisStatus unknownNCT03658863Not applicable
- A Study Comparing Sems Placement With and and Without Biliary Sphincterectomy in Patients With Malignant Biliary ObstructionStatus unknownNCT03628001Not applicable
- Fibrates in Pediatric CholestasisCompletedNCT03586674Phase 2
- Cancer of the Head of the Pancreas: Early Surgery or Preoperative Biliary Drainage?WithdrawnNCT03358095Not applicable
- A Placebo-controlled Study of Maralixibat (SHP625) in Pediatric Subjects With Progressive Familial Intrahepatic Cholestasis (PFIC)WithdrawnNCT03353454Phase 3
- Paternally Inherited Phenotypes in CholestasisStatus unknownNCT03337074
- Omegaven for Compassionate Use in the Treatment of Parenteral Nutrition-Associated Liver DiseaseApproved for marketingNCT03072667
- Remission Induction of Primary Biliary Cholangitis-autoimmune Hepatitis Overlap SyndromeStatus unknownNCT02936596Not applicable
- Expanded Access of Omegaven IV Fat Emulsion to Infants and Children With PNALDApproved for marketingNCT02929303
- Expanded Access Use of Omegaven® in the Treatment of Parenteral Nutrition Induced Liver Injury in ChildrenNo longer availableNCT02925520
- FibroScan™ in Pediatric Cholestatic Liver Disease (FORCE)CompletedNCT02922751
- Retrospective Study About Primary Biliary Cholangitis During January 2001 to July 2016 at West China HospitalCompletedNCT02917408
- Dose-escalation Study of GSK2330672 in Japanese Healthy Male VolunteersCompletedNCT02801981Phase 1
- Intravenous Fish Oils in the Treatment of Parenteral Nutrition Liver InjuryApproved for marketingNCT02780193
- Compassionate Use of OmegavenApproved for marketingNCT02778698
- Inter-regional Cohort of Neonatal and Infant Cholestasis in the Greater Southwest RegionTerminatedNCT02767648
- The Effect of Bezafibrate on Cholestatic ItchStatus unknownNCT02701166Phase 3
- A4250, an IBAT Inhibitor in Pediatric CholestasisCompletedNCT02630875Phase 2
- Endoscopic Biliary RFA of Malignant Bile Duct ObstructionStatus unknownNCT02582541Not applicable
- Intravenous Fat Emulsion Comprised of Fish Oil in the Treatment of Parenteral Nutrition Induced Liver Injury in InfantsApproved for marketingNCT02534077
- Compassionate Use of Omegaven IV Fat EmulsionNo longer availableNCT02477345
- Preventive and Reversional Effect of Vitamin D on Parenteral Nutrition Associated Liver DiseaseStatus unknownNCT02452177Not applicable
- Enteral Fish Oil is Superior to Ursodeoxycholic Acid (UDCA) and Placebo for the Treatment of Cholestasis in InfantsWithdrawnNCT02420496Phase 2
- SMOF Lipid for Children With Parenteral Nutrition Induced Liver InjuryApproved for marketingNCT02412566
- Radiological Investigation of Bile Duct ObstructionCompletedNCT02351492Not applicable
- Omegaven® as Parenteral NutritionStatus unknownNCT02334293Not applicable
- Compassionate Use of Omegaven® for the Treatment of Intestinal Failure Associated Liver Disease in ChildrenApproved for marketingNCT02328768
- Pharmacokinetic and Safety Study of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancreatic Cancer Who Have Cholestatic HyperbilirubinemiaTerminatedNCT02267707Phase 1
- Use of Omega 3 Oil Emulsion for Parenteral Nutrition Associated CholestasisNo longer availableNCT02148146